Neil Dhawan

Company: Totus Medicines

Job title: Chief Executive, Scientific Officer & Co-founder

Seminars:

Developing Ultra-High Throughput Cellular Screening of Covalent Libraries & the Advancement of a PI3K-alpha Covalent Inhibitor 12:30 pm

Elucidating the development of the first ever platform to screen billions of covalent compounds in cells in days Discussing the discovery of TOS-358, the first highly specific covalent inhibitor of PI3K-alpha Case Study: The unique properties and advantages of covalent targeting of PI3K-alphaRead more

day: Conference Day One